Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

Oday Elmanaseer; Alzira R M Avelino; Amin Azem; Mihir Raval

doi:10.1136/bcr-2021-245557

Article info

Case report

Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

Authors

Oday Elmanaseer Internal Medicine, Albany Medical Center, Albany, New York, USA PubMed articles Google scholar articles
Alzira R M Avelino Internal Medicine, Albany Medical Center, Albany, New York, USA PubMed articles Google scholar articles
Amin Azem Internal Medicine, Albany Medical Center, Albany, New York, USA PubMed articles Google scholar articles
Mihir Raval Hematology, New York Oncology and Hematology, Albany, New York, USA PubMed articles Google scholar articles

Correspondence to Dr Oday Elmanaseer; elmanao{at}amc.edu

View Full Text

Citation

Elmanaseer O, Avelino ARM, Azem A, et al

Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia

BMJ Case Reports CP 2021;14:e245557.

Publication history

Accepted November 25, 2021
First published December 22, 2021.

Online issue publication

January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password